Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota

被引：18

作者：

Matteo Garcovich ^{[1
]}

Maria Assunta Zocco ^{[1
]}

Davide Roccarina ^{[1
]}

Francesca Romana Ponziani ^{[1
]}

Antonio Gasbarrini ^{[1
]}

机构：

[1] Department of Internal Medicine, Catholic University of Sacred Heart

来源：

World Journal of Gastroenterology | 2012年 / 46期

关键词：

Hepatic encephalopathy; Gut microbiota; Cirrhosis; Non-absorbable disaccharides; Rifaximin;

D O I：

暂无

中图分类号：

R747.9 [并发神经病];

学科分类号：

1002 ;

摘要：

The gut flora plays an important role in the pathogenesis of the complications of cirrhosis. Hepatic encephalopathy (HE) represents a broad continuum of neuropsychological dysfunction in patients with acute or chronic liver disease and/or porto-systemic shunting of blood flow and it manifests with progressive deterioration of the superior neurological functions. The pathophysiology of this disease is complex, as it involves overproduction and reduced metabolism of various neurotoxins, particularly ammonia. Management of HE is diversified and requires several steps: elimination of precipitating factors, removal of toxins, proper nutritional support, modulation of resident fecal flora and downregulation of systemic and gut-derived inflammation. This review will provide an overview of gut barrier function and the influence of gut-derived factors on HE, focusing on the role of gut microbiota in the pathogenesis of HE and the recent literature findings on its therapeutic manipulation.

引用

页码：6693 / 6700

页数：8

共 25 条

[1]

Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis[J] . Ming Luo,Lei Li,Chen-Zheng Lu,Wu-Kui Cao.European Journal of Gastroenterology & Hepatology . 2011 (12)

[2] Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy [J].

Bajaj, Jasmohan S. ;

Heuman, Douglas M. ;

Wade, James B. ;

Gibson, Douglas P. ;

Saeian, Kia ;

Wegelin, Jacob A. ;

Hafeezullah, Muhammad ;

Bell, Debulon E. ;

Sterling, Richard K. ;

Stravitz, R. Todd ;

Fuchs, Michael ;

Luketic, Velimir ;

Sanyal, Arun J. .

GASTROENTEROLOGY, 2011, 140 (02) :478-U179

[3]

Contribution of Gut Bacteria to Liver Pathobiology[J] . Gakuhei Son,Michael Kremer,Ian N. Hines,Ekihiro Seki.Gastroenterology Research and Practice . 2010

[4] Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy [J].

Gupta, Ankur ;

Dhiman, Radha K. ;

Kumari, Savita ;

Rana, Satyavati ;

Agarwal, Ritesh ;

Duseja, Ajay ;

Chawla, Yogesh .

JOURNAL OF HEPATOLOGY, 2010, 53 (05) :849-855

[5] Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy [J].

Malaguarnera, Mariano ;

Gargante, Maria Pia ;

Malaguarnera, Giulia ;

Salmeri, Mario ;

Mastrojeni, Silvana ;

Rampello, Liborio ;

Pennisi, Giovanni ;

Volti, Giovanni Li ;

Galvano, Fabio .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (02) :199-206

[6]

Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test[J] . Jasmohan S. Bajaj,Kia Saeian,Christine M. Schubert,Muhammad Hafeezullah,Jose Franco,Rajiv R. Varma,Douglas P. Gibson,Raymond G. Hoffmann,R. Todd Stravitz,Douglas M. Heuman,Richard K. Sterling,Mitchell Shiffman,Allyne Topaz,Sherry Boyett,Debulon Bell,Arun J. Sanyal.Hepatology . 2009 (4)

[7]

The Liver as a Lymphoid Organ[J] . Ian Nicholas Crispe.Annual Review of Immunology . 2009

[8]

Gastrointestinal tract in liver disease: which organ is sick?[J] . Kristina Norman,Matthias Pirlich.Current Opinion in Clinical Nutrition and Metabolic Care . 2008 (5)

[9] Inhibitory Control Test for the Diagnosis of Minimal Hepatic Encephalopathy [J].